• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Results of the STOP-Hypertension-2 Trial.
Authors: Hansson L Abstract The second Swedish Trial in Old patients with Hypertension (STOP-Hypertension-2) was conducted to compare the effects of 'newer( antihypertensive therapies (angiotensin converting enzyme [ACE] inhibitors and calcium antagonists) and established therapies (beta-blockers and diuretics) on cardiovascular mortality and morbidity in elderly hypertensive patients. A total of 6614 patients were randomized to receive conventional treatment, ACE inhibitors or calcium antagonists, and followed for a mean of 5 years. The primary endpoint was a combination of fatal stroke, fatal myocardial infarctio...
Source: Blood Pressure - April 23, 2017 Category: Hematology Tags: Blood Press Source Type: research

What is resistant arterial hypertension?
CONCLUSION: RAH distinctly increases the risk of developing coronary artery disease, heart failure, stroke and chronic kidney disease and confers higher rates of major adverse cardiovascular events as well as increased all-cause mortality. Timely diagnosis and treatment of RAH may mitigate the associated risks and improve short and long-term prognosis.PMID:36891929 | DOI:10.1080/08037051.2023.2185457
Source: Blood Pressure - March 9, 2023 Category: Hematology Authors: Evgeniya V Shalaeva Franz H Messerli Source Type: research

Pages: 1  2